SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovances raised FY2026 revenue outlook, supported by stronger demand for Amtagvi and Proleukin, is driving the rally, with analyst upgrades adding momentum. Traders are celebrating the commercial progress while debating whether short-covering is amplifying the move, and many are looking ahead to lung-cancer data.

AST SpaceMobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an intellectual property and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobiles new change-of-control severance policy has fueled speculation about a possible buyout or strategic deal, though traders note the filing is not evidence that a transaction is underway. The debate is tempered by frustration over the lack of shipment and launch updates for BlueBirds 1416, with some investors focused on execution delays and others maintaining a long-term bullish view.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reports of improving user growth have fueled optimism about Reddits growth outlook, while traders remain divided over the stocks weak, volatile performance. Bears point to executive share sales and uncertainty around Googles AI data-licensing relationship; bulls argue advertising growth and user metrics support the long-term case.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas selection for a U.S. Army program to develop next-generation 10 kV silicon carbide devices is drawing attention as a validation of its technology and domestic manufacturing capabilities. Traders are divided: some see longer-term potential, while others question the impact because the award is a prototype program with no disclosed financial terms and may not bring meaningful near-term revenue.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. Its products include Gvoke, Keveyis, and Recorlev. Gvoke is a ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

A report that Lundbeck is exploring a possible acquisition of Xeris has driven a burst of attention and trading volume. Traders are debating the buyout speculation after Xeris said it is not for sale, with some seeing takeover potential and others criticizing the companys response.

Fair Isaac Corp. engages in the provision of decision management solutions. It operates through the Software and Scores segments. The Software segment includes pre-configured analytic and decision management solutions designed for a specific type of business need or process. The Scores segment focuses on business-to-business scoring solutions and services, business-to-consumer scoring solutions and services including myFICO solutions for consumers and associated professional services. The company was founded by Bill Fair and Earl Isaac in 1956 and is headquartered in San Jose, CA.

Fair Isaac Corp.

Fair, Isaac Corp.

FICO is under pressure after FHFA moved to let Fannie Mae and Freddie Mac use VantageScore alongside FICO under a unified mortgage pricing grid, raising concerns that competition could erode its mortgage-scoring advantage and pricing power. Traders are divided between viewing the selloff as an overreaction and a buying opportunity, and seeing it as a lasting threat to FICOs moat.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is under pressure as long-term Treasury yields surge amid inflation and oil-supply concerns, worries about government borrowing, and expectations that rates may stay higher or rise further. Traders are divided between expecting more bond losses and viewing the selloff as an oversold buying opportunity; they also debate whether higher yields will eventually weigh on stocks, which have so far shown resilience.

Armada Acquisition Corp. II is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combinations with one or more businesses. The company was founded on October 3, 2024 and is headquartered in Miami, FL.

Armada Acquisition Corp. II - Ordinary Shares- Class A

Evernorth Holdings Inc.

Attention centers on Evernorths Nasdaq listing and its XRP-treasury strategy, with traders viewing XRPN and its warrants as leveraged exposure to XRP. The bullish case is balanced by questions about merger execution, valuation, dilution, and the warrants risk.

Carnival Corp. Ltd. engages in the operation of cruise ships. It operates through the following business segments: North America Cruise Operations, Europe Cruise Operations, Cruise Support, and Tour and Others. The North America Cruise Operations segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. The Europe Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Carnival Corporation Ltd.

Carnival Corp

Carnivals quarterly results beat expectations and lifted its full-year outlook, with record bookings and strong cruise demand driving a sharp rally. Bulls welcomed the results and booking momentum, while skeptics pointed to fuel costs and softer fourth-quarter guidance as risks to sustaining the gains.

Churchill Capital Corp. XI is a blank check company. It was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Michael Stuart Klein on June 4, 2025 and is headquartered in New York, NY.

Churchill Capital Corp XI - Ordinary Shares - Class A

CCXI is drawing attention as Churchill Capitals planned merger with Agility Robotics offers exposure to humanoid and industrial robotics; traders point to Agilitys commercial deployments and major backers, as well as sector buzz around Unitree and potential U.S. restrictions on Chinese-made robots. Bulls see a rare public-market robotics play, while skeptics question the valuation, current revenue, execution and SPAC-related risks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

If you followed $GOEV through Canoo’s EV plans and the company’s shift away from its original business strategy, there’s an update worth knowing about. 
 
Canoo has reached a tentative settlement with investors over claims related to its engineering-services business, subscription model, and Hyundai-related commercial prospects. Shareholders who held stock between 2020 and 2021 may be eligible to participate. Check your eligibility and submit your claim: https://11th.com/cases/canoo-investor-settlement

Canoo has reached a tentative settlement to resolve investor claims that it misled the market about its engineering-services business, subscription model, an...

11th.com

Canoo ($GOEV) Investor Settlement

StockTwits Web

Canoo Inc

 through Canoo’s EV plans and the company’s shift away from its original business strategy, there’s an update worth knowing about. 
 
Canoo has reached a tentative settlement with investors over claims related to its engineering-services business, subscription model, and Hyundai-related commercial prospects. Shareholders who held stock between 2020 and 2021 may be eligible to participate. Check your eligibility and submit your claim: 